• Tetrazolium (chloride) for Viability Assays

  2026-09-07

  Tetrazolium (chloride), also called Tetrazolium Red, converts reductive enzyme activity into a visible formazan signal for cell and tissue analysis. This guide shows how to pair quantitative cell assays with ischemic brain staining, interpret mitochondrial readouts, and troubleshoot weak or misleading color development.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-09-07

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may separate poorly with conventional Tris-SDS-PAGE. It is suitable for controlled research workflows, including denaturing and non-denaturing electrophoresis, but is not intended for diagnostic, clinical, or medical use.

• CLK2 and Platinum Resistance in Ovarian Cancer

  2026-09-05

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically relevant mediator of platinum resistance in ovarian cancer and links this effect to BRCA1 phosphorylation at Ser1423. Its integrated tissue, cellular, mechanistic, and xenograft evidence supports CLK2 as a candidate target for studying DNA damage repair and treatment response.

• Necrosulfonamide Workflow for MLKL Necroptosis Assays

  2026-09-04

  Necrosulfonamide provides a pathway-focused way to test whether MLKL membrane translocation drives injury after oxidative, hypoxic, or inflammatory stress. This practical guide connects NSA dosing, membrane-integrity readouts, and the cardiac microvascular findings of a 2025 reference study to more interpretable necroptosis assays.

• Protoporphyrin IX at the Heme–Ferroptosis Nexus

  2026-09-04

  A translational framework for using Protoporphyrin IX as a photodynamic compound and heme-pathway probe while investigating iron-dependent ferroptosis in hepatocellular carcinoma.

• ICAA, HO-1, and HBV Replication: Mechanistic Insights

  2026-09-04

  The reference study shows that isochlorogenic acid A (ICAA) suppresses hepatitis B virus replication at multiple stages, including transcription, cccDNA maintenance, capsid formation, and envelopment. Its findings connect HO-1-associated reactive oxygen species modulation with altered viral structural-protein chemistry, providing a mechanistic framework for studying host-directed antiviral effects.

• Naloxone Hydrochloride: A Mechanism-First Guide

  2026-09-03

  Naloxone hydrochloride is more than a standard opioid receptor antagonist: it is a powerful tool for separating receptor-mediated signaling from receptor-independent cellular effects. This mechanism-first guide connects opioid, neural, and immune assays with practical lessons from modern inhibitor-discovery research.

• N4-Acetylcytidine: From Structure to Translation

  2026-09-02

  N4-Acetylcytidine is more than a modified nucleoside standard. Recent structural work separates free ac4C metabolism from RNA-embedded modification biology, providing a sharper framework for enzyme assays, RNA structure-function analysis, reagent selection, and translational interpretation.

• ICG001 for Reliable Wnt Assays

  2026-09-02

  Learn how ICG001 (SKU A8217) can improve interpretation of cell viability, proliferation, and cytotoxicity experiments involving Wnt/β-catenin signaling. This scenario-based guide covers mechanism, assay design, dosing, controls, compound handling, and vendor-selection criteria.

• TG003 and the Translational Logic of CLK2 Biology

  2026-09-01

  TG003 offers a reversible pharmacological route to interrogate Cdc2-like kinase biology, alternative splicing, and the CLK2–BRCA1 axis implicated in platinum resistance. This thought-leadership analysis connects splice-factor phosphorylation with translational study design while distinguishing validated evidence from forward-looking hypotheses.

• Quizartinib (AC220) Workflow for FLT3 Studies

  2026-09-01

  Build reproducible FLT3 pathway experiments with Quizartinib (AC220), from phospho-protein assays and AML cell viability studies to resistance-aware xenograft workflows. A cross-domain section uses recent norovirus–NINJ1 findings to sharpen assay controls without implying that Quizartinib directly regulates viral secretion.

• AA–HMF Co-exposure and Ferroptotic Gut Injury

  2026-08-31

  A 2026 Food Bioscience study shows that simultaneous exposure to acrylamide and 5-hydroxymethylfurfural damages IEC-6 intestinal epithelial cells through redox imbalance, mitochondrial dysfunction, and ferroptosis-associated signaling. Its combination of pharmacological rescue, molecular profiling, and transcriptomics provides a useful framework for distinguishing ferroptotic injury from general oxidative cytotoxicity.

• dhcr7 Knockout Grass Carp Shows GCRV Resistance

  2026-08-31

  A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found approximately 40% higher survival after GCRV-II challenge. The work links cholesterol biosynthesis with antiviral immunity in vivo, identifying dhcr7 as a disease-resistance breeding target without detectable penalties for growth or muscle morphology.

• A Broad-Spectrum mRNA Vaccine for Omicron and SARS-CoV

  2026-08-30

  Guan and colleagues engineered a lipid nanoparticle-encapsulated mRNA vaccine that replaces the mutable SARS-CoV-2 Omicron RBD with a conserved SARS-CoV RBD. In mice, this design generated cross-reactive neutralizing antibodies and protection against both Omicron and SARS-CoV, supporting antigen architecture as a strategy for broader coronavirus mRNA vaccine development.

• (S)-(+)-Methoprene Workflows for JH Research

  2026-08-29

  (S)-(+)-Methoprene is a practical juvenile hormone analog for separating receptor-driven developmental effects from upstream hormone-biosynthesis regulation. This workflow-focused guide shows how to pair Met activation with miRNA, transcriptional, developmental, and comparative receptor assays while avoiding common dosing and stability errors.

8032 records 1/536 page Next 12345 下5页 Last page